Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Sakurai

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|February 24, 2020
Involvement of Caveolin-1-mediated transcytosis in the intratumoral accumulation of liposomesYu Sakurai, Akari Kato, Hideyoshi Harashima
Biological & Pharmaceutical Bulletin|August 4, 2015
Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to HepatocytesYu Sakurai, Takashi Matsuda, Tomoya Hada, et al.
Advanced Drug Delivery Reviews|July 11, 2020
Development of lipid-like materials for RNA delivery based on intracellular environment-responsive membrane destabilization and spontaneous collapseHiroki Tanaka, Yu Sakurai, Jessica Anindita, et al.
Expert Opinion on Drug Delivery|November 8, 2014
Advances in an active and passive targeting to tumor and adipose tissuesYu Sakurai, Kazuaki Kajimoto, Hiroto Hatakeyama, et al.
Biological & Pharmaceutical Bulletin|February 4, 2017
Modifying Cationic Liposomes with Cholesteryl-PEG Prevents Their Aggregation in Human Urine and Enhances Cellular Uptake by Bladder Cancer CellsTakashi Nakamura, Yosuke Noma, Yu Sakurai, et al.
Molecular Pharmaceutics|May 8, 2014
Improvement of doxorubicin efficacy using liposomal anti-polo-like kinase 1 siRNA in human renal cell carcinomasYu Sakurai, Hiroto Hatakeyama, Hidetaka Akita, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 14, 2017
Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticlesShoshiro Yamamoto, Akari Kato, Yu Sakurai, et al.
Pharmaceutics|September 28, 2021
Optimization of Sentinel Lymph Node Imaging Methodology Using Anionic Liposome and HyaluronidaseYu Sakurai, Miho Suzuoki, Masaki Gomi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 22, 2024
[A Case of Pathological Complete Response Following Neoadjuvant S-1 Monotherapy in an Elderly Patient with Locally Advanced Breast Cancer]Takayuki Terasawa, Yu Sakurai, Ai Yanai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2017
Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modelingJoseph W Nichols, Yu Sakurai, Hideyoshi Harashima, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|February 24, 2020
Involvement of Caveolin-1-mediated transcytosis in the intratumoral accumulation of liposomesYu Sakurai, Akari Kato, Hideyoshi Harashima
Biological & Pharmaceutical Bulletin|August 4, 2015
Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to HepatocytesYu Sakurai, Takashi Matsuda, Tomoya Hada, et al.
Advanced Drug Delivery Reviews|July 11, 2020
Development of lipid-like materials for RNA delivery based on intracellular environment-responsive membrane destabilization and spontaneous collapseHiroki Tanaka, Yu Sakurai, Jessica Anindita, et al.
Expert Opinion on Drug Delivery|November 8, 2014
Advances in an active and passive targeting to tumor and adipose tissuesYu Sakurai, Kazuaki Kajimoto, Hiroto Hatakeyama, et al.
Biological & Pharmaceutical Bulletin|February 4, 2017
Modifying Cationic Liposomes with Cholesteryl-PEG Prevents Their Aggregation in Human Urine and Enhances Cellular Uptake by Bladder Cancer CellsTakashi Nakamura, Yosuke Noma, Yu Sakurai, et al.
Molecular Pharmaceutics|May 8, 2014
Improvement of doxorubicin efficacy using liposomal anti-polo-like kinase 1 siRNA in human renal cell carcinomasYu Sakurai, Hiroto Hatakeyama, Hidetaka Akita, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 14, 2017
Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticlesShoshiro Yamamoto, Akari Kato, Yu Sakurai, et al.
Pharmaceutics|September 28, 2021
Optimization of Sentinel Lymph Node Imaging Methodology Using Anionic Liposome and HyaluronidaseYu Sakurai, Miho Suzuoki, Masaki Gomi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 22, 2024
[A Case of Pathological Complete Response Following Neoadjuvant S-1 Monotherapy in an Elderly Patient with Locally Advanced Breast Cancer]Takayuki Terasawa, Yu Sakurai, Ai Yanai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2017
Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modelingJoseph W Nichols, Yu Sakurai, Hideyoshi Harashima, et al.
Pageof 8